EX-2.1
from 8-K
81 pages
Agreement and Plan of Merger Among Equillium, Inc., Metacrine, Inc., Equillium Acquisition Sub, Inc. and Triumph Merger Sub, Inc. Dated as of September 6, 2022
12/34/56
EX-2.1
from 8-K
87 pages
[***] = Certain Confidential Information Contained in This Document, Marked by Bracketed Asterisks, Has Been Omitted Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed Agreement and Plan of Merger by and Among Equillium, Inc.; Project Jetfuel Merger Sub, Inc.; Bioniz Therapeutics, Inc. and Kevin Green, as the Securityholders’ Representative Dated as of February 14, 2022
12/34/56
